Drugmaker Roche said it is suspending recruitment into a trial of Cera in anemic lung cancer patients because of an "imbalance" of deaths across the four arms of the study, which was conducted outside the U.S.
For moe, go here.
Drugmaker Roche said it is suspending recruitment into a trial of Cera in anemic lung cancer patients because of an "imbalance" of deaths across the four arms of the study, which was conducted outside the U.S.
For moe, go here.
